Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |